Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02665208Completed
Randomised, open-label trial in Tobacco Use Disorder (TUD) (2 arms), sponsored by NYU Langone Health. Primary endpoints: Difference in patient acceptability assessed via rates of participant adoption of TMI at 24 weeks, Feasibility measured by rates of retention in the TMI at 24 weeks and 1 more. Started Mar 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02665208.